Tien Liang BioTech Co., Ltd. (TPEX:4127)
Taiwan
· Delayed Price · Currency is TWD 36.60
-0.05 (-0.14%)
Jun 20, 2025, 1:30 PM CST
Tien Liang BioTech Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 21.76 | 11.7 | 17.73 | 59.48 | 46.61 | -51.64 | Upgrade
|
| Depreciation & Amortization | 9.14 | 9.15 | 10.44 | 10.76 | 11.97 | 14.3 | Upgrade
|
| Other Amortization | 0.17 | 0.16 | 0.11 | 0.29 | 0.46 | 0.55 | Upgrade
|
| Loss (Gain) From Sale of Assets | -2.25 | -2.25 | -0.57 | -0.03 | - | -0.16 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | - | - | 1.31 | Upgrade
|
| Other Operating Activities | -15.84 | -8.03 | -0.66 | -0.02 | 2.23 | -1.11 | Upgrade
|
| Change in Accounts Receivable | -8.3 | -0.73 | 15.42 | -3.4 | -4.69 | 13.71 | Upgrade
|
| Change in Inventory | 10.33 | 17.31 | 19.17 | -34.02 | -8.37 | 5.25 | Upgrade
|
| Change in Accounts Payable | 33.21 | 10.96 | -1.2 | -8.91 | 6.29 | -9.53 | Upgrade
|
| Change in Unearned Revenue | - | - | - | - | -2.89 | 0.38 | Upgrade
|
| Change in Other Net Operating Assets | -4.01 | 10.09 | 9.23 | -2.27 | -6.4 | 16.13 | Upgrade
|
| Operating Cash Flow | 44.21 | 48.34 | 69.67 | 21.88 | 45.21 | -10.82 | Upgrade
|
| Operating Cash Flow Growth | -61.07% | -30.61% | 218.42% | -51.60% | - | - | Upgrade
|
| Capital Expenditures | -4.92 | -4.05 | -4.96 | -1.01 | -0.6 | -1.09 | Upgrade
|
| Sale of Property, Plant & Equipment | 3.84 | 3.84 | 0.6 | 0.1 | - | 0.16 | Upgrade
|
| Sale (Purchase) of Intangibles | -0.1 | -0.1 | -0.38 | - | - | -0.4 | Upgrade
|
| Investment in Securities | -427.11 | -300.13 | - | - | - | 1.2 | Upgrade
|
| Other Investing Activities | -0.95 | -1.08 | -0.03 | -0.3 | -0.58 | 0.48 | Upgrade
|
| Investing Cash Flow | -429.23 | -301.51 | -4.78 | -1.21 | -1.18 | 0.35 | Upgrade
|
| Short-Term Debt Issued | - | 265 | - | - | - | 88.79 | Upgrade
|
| Total Debt Issued | 385 | 265 | - | - | - | 88.79 | Upgrade
|
| Short-Term Debt Repaid | - | - | -30 | -30.5 | -40 | - | Upgrade
|
| Long-Term Debt Repaid | - | -0.5 | -0.52 | -0.8 | -0.8 | -50.38 | Upgrade
|
| Total Debt Repaid | -0.5 | -0.5 | -30.52 | -31.3 | -40.8 | -50.38 | Upgrade
|
| Net Debt Issued (Repaid) | 384.5 | 264.5 | -30.52 | -31.3 | -40.8 | 38.41 | Upgrade
|
| Common Dividends Paid | -22.88 | -22.88 | - | - | - | - | Upgrade
|
| Financing Cash Flow | 361.62 | 241.62 | -30.52 | -31.3 | -40.8 | 38.41 | Upgrade
|
| Net Cash Flow | -23.4 | -11.55 | 34.37 | -10.63 | 3.23 | 27.94 | Upgrade
|
| Free Cash Flow | 39.29 | 44.3 | 64.71 | 20.87 | 44.61 | -11.91 | Upgrade
|
| Free Cash Flow Growth | -64.24% | -31.54% | 210.05% | -53.22% | - | - | Upgrade
|
| Free Cash Flow Margin | 10.23% | 11.50% | 14.07% | 3.95% | 7.81% | -2.76% | Upgrade
|
| Free Cash Flow Per Share | 0.86 | 0.97 | 1.41 | 0.46 | 0.97 | -0.26 | Upgrade
|
| Cash Interest Paid | 4.5 | 2.89 | 2.1 | 1.69 | 1.8 | 1.92 | Upgrade
|
| Cash Income Tax Paid | 0.82 | 0.82 | 0.06 | 0.01 | -0 | -0.01 | Upgrade
|
| Levered Free Cash Flow | 43.6 | 52.22 | 56.67 | -4.55 | 20.7 | 2.82 | Upgrade
|
| Unlevered Free Cash Flow | 46.41 | 54.15 | 57.97 | -3.44 | 21.86 | 4.05 | Upgrade
|
| Change in Net Working Capital | -41.1 | -48.61 | -40.96 | 49.91 | 16.81 | -22.37 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.